SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 154 0 LGND
Emcee:  Henry Niman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
30359 Skeeter, if you're looking at a retirement portfolio, 2 years *is* a short Torben Noerup Nielsen-1/21/2000
30358 i have had to redefine the "short" run as 2 years or more...Skeeter Bug-1/21/2000
30357 Skeeter, The market doesn't always appear rational in the short term. But Torben Noerup Nielsen-1/21/2000
30356 >>The genomes *will* be sequenced and we *will* become able to makeSkeeter Bug-1/21/2000
30355 Skeeter, I do not think you're looking at a flash in the pan with this movTorben Noerup Nielsen-1/21/2000
30354 Andreas, given that I own a nice big chunk of NABI that I just managed to get bTorben Noerup Nielsen-1/21/2000
30353 i'm happy with strength around $15. let's hope it holds and develops iSkeeter Bug-1/21/2000
30352 >>I have to complain that my big Ligand position is dragging down the perSkeeter Bug-1/21/2000
30351 Gregory, I didn't take it otherwise. It's just that there's a certTorben Noerup Nielsen-1/21/2000
30350 I have to complain that my big Ligand position is dragging down the performanceAndreas Helke-1/21/2000
30349 Torben, don't get me wrong, I am very pleased with LGND's price movemenGregory Rasp-1/21/2000
30348 Gregory, I think you're seeing sector formation in the biotech industry. LTorben Noerup Nielsen-1/21/2000
30347 An interesting thought or perhaps just drivel but is LGND really a biotech compGregory Rasp-1/21/2000
30346 Bob, Look closely and you'll see that Elan is an octopus with lots of armsTorben Noerup Nielsen-1/21/2000
30345 Bob, Look closely and you'll see that Elan is an octopus with lots of armsTorben Noerup Nielsen-1/21/2000
30344 not only does Elan own a big stake in LGND, they just bought a big stake in RZYbob zagorin-1/21/2000
30343 Thanks, Bob, for the article. Re: suspended rules of valuation. Beg to differ:N-1/21/2000
30342 Bob, Thanks. Both for the article and the BOP update. Interestingly enough, weTorben Noerup Nielsen-1/21/2000
30341 on the subject of valuation, a very interesting article. fastcompany.com TNN abob zagorin-1/21/2000
30340 Cheryl, The rules for valuation had already been suspended for a long time forAlper H.YUKSEL-1/21/2000
30339 > Overall, I'm disappointed with LGND's price movement in this markeCheryl Galt-1/21/2000
30338 I agree Henry. An analagous situation is that of antibiotic treatment. CurrenGregory Rasp-1/20/2000
30337 Cheryl - <I love Russian novels, but it IS a challenge to keep the names stRichard Belanger-1/20/2000
30336 Skeeter, It was a good day overall. But I'm afraid we're going to neeTorben Noerup Nielsen-1/20/2000
30335 we're hangin' in strong so far...Skeeter Bug-1/20/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News